Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-B: Implication in breast cancer metastasis

Oncogene

Volumn 30, Issue 28, 2011, Pages 3174-3185

  Bist, P ^a   Leow, S C ^a   Phua, Q H ^a   Shu, S ^a   Zhuang, Q ^a   Loh, W T ^a   Nguyen, T H ^a   Zhou, J B ^a   Hooi, S C ^b   Lim, L H K ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CXCR4; metastasis; NF B; transcription factor

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL FILTRATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SURVIVAL;

ANIMALS; ANNEXIN A1; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; GENE SILENCING; HUMANS; I-KAPPA B KINASE; MICE; NEOPLASM METASTASIS; NF-KAPPA B; PROTEIN BINDING; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 79960348853     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.28     Document Type: Article

References (37)

1. Ahn SH, Sawada H, Ro JY, Nicolson GL. (1997). Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 15: 151-156. (Pubitemid 27157817)
2. Ang EZ, Nguyen HT, Sim HL, Putti TC, Lim LH. (2009). Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Mol Cancer Res 7: 266-274.
3. Balkwill F. (2004). Cancer and the chemokine network. Nat Rev Cancer 4: 540-550. (Pubitemid 38868623)
4. Burger JA, Kipps TJ. (2006). CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761-1767. (Pubitemid 43289351)
5. Cabioglu N, Sahin A, Doucet M, Yavuz E, Igci A, E OY et al. (2005). Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis 22: 39-46. (Pubitemid 41185860)
6. Cao Y, Li Y, Edelweiss M, Arun B, Rosen D, Resetkova E et al. (2008). Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol 16: 530-534.
7. Chen G, Cao P, Goeddel DV. (2002). TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9: 401-410. (Pubitemid 34195564)
8. Cicek M, Samant RS, Kinter M, Welch DR, Casey G. (2004). Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 21: 149-157. (Pubitemid 38988088)
9. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J et al. (2010). Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA 107: 6340-6345.
10. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. (2006). Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22: 245-257.
11. Flower RJ, Rothwell NJ. (1994). Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15: 71-76. (Pubitemid 24086941)
12. Ghosh S, Karin M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl): S81-S96.
13. Hayden MS, Ghosh S. (2004). Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
14. Helbig G, Christopherson 2nd KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD et al. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638. (Pubitemid 36792563)
15. Karin M, Cao Y, Greten FR, Li ZW. (2002). NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310. (Pubitemid 37328783)
16. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ et al. (2007). Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12: 131-144. (Pubitemid 47208626)
17. Kreunin P, Yoo C, Urquidi V, Lubman DM, Goodison S. (2007). Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 7: 299-312. (Pubitemid 46184092)
18. Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC. (2005). Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res 65: 9891-9898. (Pubitemid 41541469)
19. Lim LH, Pervaiz S. (2007). Annexin 1: the new face of an old molecule. FASEB J 21: 968-975. (Pubitemid 46495688)
20. Mehta SA, Christopherson KW, Bhat-Nakshatri P, Goulet Jr. RJ, Broxmeyer HE, Kopelovich L et al. (2007). Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene 26: 3329-3337. (Pubitemid 46788879)
21. Monks NR, Pardee AB. (2006). Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. J Cell Biochem 98: 221-233.
22. Mukhina S, Stepanova V, Traktouev D, Poliakov A, Beabealashvilly R, Gursky Y et al. (2000). The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem 275: 16450-16458. (Pubitemid 30398865)
23. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al. (2001). Involvment of chemokine receptors in breast cancer metastasis. Nature 410: 50-56. (Pubitemid 32225831)
24. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr. RJ, Sledge Jr. GW. (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639. (Pubitemid 27281838)
25. Nakshatri H, Goulet Jr. RJ. (2002). NF-kappaB and breast cancer. Curr Probl Cancer 26: 282-309.
26. Palkowitsch L, Leidner J, Ghosh S, Marienfeld RB. (2008). Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. J Biol Chem 283: 76-86.
27. Parente L, Solito E. (2004). Annexin 1: more than an antiphospholipase protein. Inflamm Res 53: 125-132. (Pubitemid 38526595)
28. Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S et al. (2000). Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene 19: 4159-4169.
29. Pencil SD, Toth M. (1998). Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Clin Exp Metastasis 16: 113-121. (Pubitemid 28252918)
30. Perretti M, Gavins FN. (2003). Annexin 1: an endogenous antiinflammatory protein. News Physiol Sci 18: 60-64.
31. Poyet JL, Srinivasula SM, Lin JH, Fernandes-Alnemri T, Yamaoka S, Tsichlis PN et al. (2000). Activation of the Ikappa B kinases by RIP via IKKgamma/NEMO-mediated oligomerization. J Biol Chem 275: 37966-37977. (Pubitemid 32004918)
32. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. (1999). IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356.
33. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y et al. (2005). Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 326: 218-227. (Pubitemid 39573222)
34. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S et al. (2006). Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 37: 1583-1591. (Pubitemid 44792225)
35. Strieter RM. (2001). Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2: 285-286. (Pubitemid 33706336)
36. Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M et al. (2002). Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160: 1143-1153. (Pubitemid 34224600)
37. Zhang Z, Huang L, Zhao W, Rigas B. (2010). Annexin 1 induced by antiinflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70: 2379-2388.